Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 06-2022 | 03-2022 | |
| Sales | 1,123 | 24 | 0 | 0 | 1,613 |
| Gross Profit | 1,123 | 24 | N/A | N/A | 1,613 |
| Operating Expenses | 20,293 | 16,056 | 0 | 0 | 19,274 |
| Operating Income | -19,170 | -16,032 | N/A | N/A | -17,661 |
| Other Income | 1,649 | 803 | 0 | 0 | -3,399 |
| Pre-tax Income | -17,521 | -15,229 | 0 | 0 | -21,060 |
| Income Tax | 305 | 73 | N/A | N/A | 1,587 |
| Net Income Continuous | -17,826 | -15,302 | N/A | N/A | -22,647 |
| Net Income | $-17,826 | $-15,302 | $N/A | $N/A | $-22,647 |
| EPS Basic Total Ops | -0.32 | -0.34 | N/A | N/A | -0.59 |
| EPS Basic Continuous Ops | -0.32 | -0.34 | N/A | N/A | -0.59 |
| EPS Diluted Total Ops | -0.32 | -0.34 | N/A | N/A | -0.59 |
| EPS Diluted Continuous Ops | -0.32 | -0.34 | N/A | N/A | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.05 | N/A | N/A | N/A |
| EBITDA(a) | $-18,829 | $-15,966 | $N/A | $N/A | $-17,103 |